ArticleBMC medical genomics2025
Identification of an F8 complex recombination in Chinese hemophilia a patient using long-read sequencing and optical genome mapping.
Article in BMC medical genomics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Comment on "Capacity of Understanding the Future Approaches in Cancer Treatment by Multiple Models of Artificial Intelligence".Journal of cancer education : the official journal of the American Association for Cancer Education · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
Abstract
backgroundHemophilia A (HA) is an X-linked recessive bleeding disorder caused by pathogenic variants in the F8 gene, resulting in deficient coagulation factor VIII activity. Although intron 22 and intron 1 inversions (Inv22 and Inv1) accounts for approximately 50% of severe HA cases, complex structural rearrangements mediated by intron 22 homologous region (int22h) repeats have rarely reported and poorly characterized.
methodsIn this study, we investigated a Chinese severe HA pedigree with a complex rearrangement of F8 gene by integrating 750 K SNP arrays, long-read sequencing (Oxford Nanopore Technologies, ONT), and optical genome mapping (OGM). This multi-platform strategy enabled comprehensive characterization of the structural variations affecting the F8 gene.
resultsWe identified a complex rearrangement in the proband’s F8 gene, characterized by sequential duplications inserted within intron 22. These include a 7.75 kb direct duplication involving a portion of int22h-1, a 78.78 kb inverted duplication containing partial sequences of int22h-3 and int22h-2, and an 86.56 kb direct duplication spanning a portion of int22h-3 and exons 2–8 of the TMLHE gene. The structural variation in the F8 gene of the proband was inherited from the mother.
conclusionOur findings revealed that the complex rearrangement of F8 is the genetic cause of HA in this pedigree. The combined use of OGM and ONT provides an effective approach for deciphering the characterization of complex structural variants and determining the orientation of inserted segments, although base-precision breakpoint mapping remains challenging in highly homologous regions.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.